Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders.

Press RD, Bauer KA, Kujovich JL, Heit JA.

Arch Pathol Lab Med. 2002 Nov;126(11):1304-18. Review.

PMID:
12421138
2.

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2011 Jan;13(1):67-76. doi: 10.1097/GIM.0b013e3181fbe46f.

PMID:
21150787
3.

Clinical and laboratory management of the prothrombin G20210A mutation.

McGlennen RC, Key NS.

Arch Pathol Lab Med. 2002 Nov;126(11):1319-25. Review.

PMID:
12421139
4.

Diagnosis and management of factor V Leiden.

Campello E, Spiezia L, Simioni P.

Expert Rev Hematol. 2016 Dec;9(12):1139-1149. Epub 2016 Oct 31. Review.

PMID:
27797270
5.

Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.

Price DT, Ridker PM.

Ann Intern Med. 1997 Nov 15;127(10):895-903. Review.

PMID:
9382368
6.

Factor V Leiden thrombophilia.

Kujovich JL.

Genet Med. 2011 Jan;13(1):1-16. doi: 10.1097/GIM.0b013e3181faa0f2. Review.

PMID:
21116184
7.

Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.

Tirado I, Mateo J, Soria JM, Oliver A, Borrell M, Coll I, Vallvé C, Souto JC, Martínez-Sánchez E, Fontcuberta J.

Haematologica. 2001 Nov;86(11):1200-8.

8.

Factor V Leiden mutation in women with early recurrent pregnancy loss: a meta-analysis and systematic review of the causal association.

Sergi C, Al Jishi T, Walker M.

Arch Gynecol Obstet. 2015 Mar;291(3):671-9. doi: 10.1007/s00404-014-3443-x. Epub 2014 Sep 6. Review.

PMID:
25193429
9.
10.

Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.

Couturaud F, Duchemin J, Leroyer C, Delahousse B, Abgrall JF, Mottier D; Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).

Thromb Haemost. 2008 Jan;99(1):223-8. doi: 10.1160/TH07-08-0515.

PMID:
18217158
11.

Factor V Leiden mutation: a treatable etiology for sporadic and recurrent pregnancy loss.

Glueck CJ, Gogenini S, Munjal J, Tracy T, Pranikoff J, Wang P.

Fertil Steril. 2008 Feb;89(2):410-6. Epub 2007 Jun 19.

PMID:
17582408
12.

Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?

Schambeck CM, Schwender S, Haubitz I, Geisen UE, Grossmann RE, Keller F.

Thromb Haemost. 1997 Dec;78(6):1480-3.

PMID:
9423798
13.

[Diagnosis of thrombophilia based on coagulation and genetic studies].

Bałszan-Kowalska I.

Ann Acad Med Stetin. 2002;48:179-93. Polish.

PMID:
14601477
14.

Inherited thrombophilia screening in Greek women with recurrent fetal loss.

Mougiou A, Androutsopoulos G, Karakantza M, Theodori E, Decavalas G, Zoumbos N.

Clin Exp Obstet Gynecol. 2008;35(3):172-4.

PMID:
18754285
15.

Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias.

Villani M, Tiscia GL, Margaglione M, Colaizzo D, Fischetti L, Vergura P, Grandone E.

J Thromb Haemost. 2012 Feb;10(2):223-8. doi: 10.1111/j.1538-7836.2011.04583.x.

16.

Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.

Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR.

J Pediatr Gastroenterol Nutr. 2002 Nov;35(5):629-35.

PMID:
12454577
17.

Factor V Leiden in patients with venous thrombosis in Slovak population.

Simkova M, Batorova A, Dostalova K, Pozgayova S, Simko F, Kovacs L.

Gen Physiol Biophys. 2004 Dec;23(4):435-42.

18.

[Diagnosis of thrombophilia]].

Kemkes-Matthes B.

Zentralbl Chir. 2001 Jun;126(6):433-7. German.

PMID:
11446062
19.

The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.

Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G Jr, Wenstrom K, Samuels P, Cotroneo MA, Moawad A, Sorokin Y, Meis P, Miodovnik M, O'Sullivan MJ, Conway D, Wapner RJ, Gabbe SG; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Obstet Gynecol. 2005 Sep;106(3):517-24.

PMID:
16135581
20.

Thrombophilias and recurrent pregnancy loss.

Kutteh WH, Triplett DA.

Semin Reprod Med. 2006 Feb;24(1):54-66. Review.

PMID:
16418978

Supplemental Content

Support Center